Results 111 to 120 of about 278,280 (389)
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract Biochar has attracted considerable attention in recent years for its wide‐ranging applications, particularly its role in carbon sequestration as a strategy to mitigate greenhouse gas emissions. Its emerging uses within the circular bioeconomy also position it as a valuable tool for environmental management, and ongoing research continues to ...
Jean Agustin Velasquez‐Pinas +6 more
wiley +1 more source
The Capital Asset Pricing Model: An Application on the Efficiency of Financing Higher Public Education in Egypt [PDF]
In the Markowitz (1952) mean-variance model as well as the Capital Asset Pricing Model of Sharpe (1964) and Lintner (1965) agents make their investment decisions based solely on the expected return and variance.
Nevine Mokhtar Eid
core
Trading Volume: Implications of an Intertemporal Capital Asset Pricing Model [PDF]
, 2001 Andrew W. Lo, Jiang Wang
openalex +1 more source
Production of a nutrient enriched biochar: a techno‐economic feasibility analysis
Biofuels, Bioproducts and Biorefining, EarlyView.Abstract A techno‐economic feasibility analysis was conducted for a biomass pyrolysis plant that utilized Eucalyptus to produce fertilizer‐enriched biochar. Key parameters – biomass throughput, fertilizer loading, and selling price – were optimized for financial viability using net present value (NPV), internal rate of return (IRR), return on ...
Brendon Trollip, Ryan David Merckel
wiley +1 more source
CAPM (Capital Asset Pricing Model) with Stable Distribution
Jurnal Ilmu Dasar, 2010 In the classical finance theory, the CAPM models are developed using the Gaussian framework, that is, weassume the vector of returns can be modeled using the multivariate normal distribution.
Dedi Rosadi
doaj
British Journal of Clinical Pharmacology, EarlyView.Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló +5 more
wiley +1 more source
Intertemporal Asset Pricing: Preliminary Evidence from an Emerging Economy
The Lahore Journal of Business, 2013 In this paper, we test a simple Merton-style (1973) intertemporal capital asset pricing model (ICAPM) by allowing for time variations in certain key state variables for a sample of firms listed on the Karachi Stock Exchange.
Amna Rehman, Nawazish Mirza
doaj
The Evolution of Portfolio Rules and the Capital Asset Pricing Model [PDF]
, 2002 Emanuela Sciubba
openalex +1 more source
Biodiversity Credits: An Overview of the Current State, Future Opportunities, and Potential Pitfalls
Business Strategy and the Environment, EarlyView.ABSTRACT Biodiversity credits are an emerging vehicle for pro‐environmental financing, yet much uncertainty remains around how and when they could boost biodiversity conservation. Here we define what biodiversity credits are and explore impact pathways through a proposed theory of change. Based on evidence from 34 pilot projects and a review of lessons
Sven Wunder +16 more
wiley +1 more source
Can the Consumption-Free Nonexpected Utility Model Solve the Risk PremiumPuzzle? An Empirical Study of the Japanese Stock Market [PDF]
This paper investigates whether the consumption-free two-beta intertemporal capital asset-pricing model developed by Campbell and Vuolteenaho (2004) is able to solve the risk premium puzzle in the Japanese stock market over the period 1984−@2002.
Myong-Il Kang
core